ATOSSA THERAPEUTICS, INC. Shares Outstanding

Quick Answer

ATOSSA THERAPEUTICS, INC. reported Shares Outstanding of 8.61 million shares for fiscal year 2025.

ATOSSA THERAPEUTICS, INC. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 8.61M +0.0%
2024 8.61M -93.1%
2023 125.30M -1.0%
2022 126.62M +0.0%
2021 126.62M +166.3%
2020 47.55M +420.8%
2019 9.13M +56.2%
2018 5.85M +120.5%
2017 2.65M -30.0%
2016 3.79M +73.9%
2015 2.18M -91.1%
2014 24.56M +32.2%
2013 18.57M +43.8%
2012 12.92M +14.8%
2011 11.26M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 129.17M +3.1% +0.0%
June 30, 2025 129.17M +3.1% +0.0%
March 31, 2025 129.17M +2.9% +0.0%
December 31, 2024 129.17M +3.1% +3.1%
September 30, 2024 125.30M +0.0% +0.0%
June 30, 2024 125.30M -0.9% -0.2%
March 31, 2024 125.51M -0.9% +0.2%
December 31, 2023 125.30M -1.0% +0.0%
  • ATOSSA THERAPEUTICS, INC. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2011–2025 period, ATOSSA THERAPEUTICS, INC.’s shares outstanding has declined by 23.5% (from 11.26 million shares to 8.61 million shares).
  • The most recent figure is from ATOSSA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment